Journal article

Safety and immunogenicity of concurrent administration of live attenuated influenza vaccine with measles-mumps-rubella and varicella vaccines to infants 12 to 15 months of age

Terry Nolan, David I Bernstein, Stan L Block, Milo Hilty, Harry L Keyserling, Colin Marchant, Helen Marshall, Peter Richmond, Ram Yogev, Julie Cordova, Iksung Cho, Paul M Mendelman

PEDIATRICS | AMER ACAD PEDIATRICS | Published : 2008

Abstract

OBJECTIVE: This study evaluated the safety, tolerability, and immunogenicity of live attenuated influenza vaccine administered concurrently with measles-mumps-rubella vaccine and varicella vaccine to healthy children 12 to 15 months of age. METHODS: Children were assigned randomly to receive (1) measles-mumps-rubella vaccine, varicella vaccine, and intranasal placebo on day 0, followed by 1 dose of live attenuated influenza vaccine on days 42 and 72; (2) measles-mumps-rubella, varicella, and live attenuated influenza vaccines on day 0, followed by a second dose of live attenuated influenza vaccine on day 42 and intranasally administered placebo on day 72; or (3) 1 dose of live attenuated inf..

View full abstract

University of Melbourne Researchers